They activate GLP-1 receptors, promoting insulin secretion while also inhibiting glucagon secretion from the pancreas
"A young man escalated his dose of retatrutide, he experienced secretory diarrhoea, which was very severe, and he was admitted to hospital requiring a lot of intravenous fluid rehydration," Dr Holt said
Chemistry & Structural Modification Retatrutide is a long-chain polypeptide bearing a non-natural -methylleucine residue, two aminoisobutyric acid residues, and a polyethylene-glycol-linked -glutamyl-eicosanedioic-acid side chain conjugated to a central lysine
Because Retatrutide influences multiple metabolic pathways, careful adjustment is essential to ensure balanced and predictable physiological effects
Seek urgent or same-day medical attention if you experience: Severe, persistent upper abdominal pain, with or without vomiting this may indicate pancreatitis, a recognised class warning with GLP-1-based therapies
In fact, its expected to pump around $600 million into the generic drug industry in just the next 12 to 15 months
